Leber Laura 4
4 · GENOMIC HEALTH INC · Filed Oct 21, 2019
Insider Transaction Report
Form 4
Leber Laura
Chief Communication Officer
Transactions
- Gift
Common Stock
2019-03-11−275→ 13,420 total - Sale
Common Stock
2019-10-17$70.94/sh−13,183$935,228→ 13,736 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-10-17−13,183→ 0 totalExercise: $22.98Exp: 2021-01-27→ Common Stock (13,183 underlying) - Exercise/Conversion
Common Stock
2019-10-17$22.98/sh+13,183$302,945→ 26,919 total
Footnotes (5)
- [F1]Includes an aggregate of 9,384 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F2]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 14, 2018.
- [F3]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F4]Represents weighted average sale price. Actual sale prices ranged from $70.71 to $71.135.
- [F5]The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter.